CV Lattes
Universidade Estadual Paulista (UNESP). Campus de Araraquara. Faculdade de Ciências Farmacêuticas (FCFAR) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Pharmacist-Biochemist (São Paulo State University UNESP, 2015), with a Masters degree in Pharmaceutical Sciences (UNESP, 2018), a Ph.D. in Toxicology (University of São Paulo FCFRP-USP, 2024), and a Ph.D. in Pharmaceutical Sciences (University of Florida College of Pharmacy, ongoing). Currently serves as a Graduate Assistant at the Center for Pharmacometrics Systems Pharmacology (CPSP), University of Florida. Completed internships in Pharmacometrics and Clinical Pharmacology at Eli Lilly and Company (Indianapolis, USA, 2024) and Johnson Johnson Innovative Medicine (Spring House, USA, 2025). Has experience in population and physiologically based pharmacokinetic modeling (popPK and PBPK), clinical pharmacokinetics, pharmacogenetics, and bioanalytical method development. Scientific contributions focus on drug disposition in special populations (such as post-bariatric surgery patients and critically ill cancer patients), with an emphasis on model-informed drug development (MIDD) and personalized pharmacotherapy. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The translation initiation factor 5A (eIF5A) is a highly conserved protein in archae and eukaryotic cells and essential for cellular viability. This factor is the only cellular protein that undergoes an essential posttranslational modification dependent on the polyamine spermidine, called hypusination. Although this protein was originally identified as a translation initiation factor, sub…
| 1 / 1 | Completed scholarships in Brazil |
| Associated processes | |